Back to Search
LAKE SEYMOUR, DMD
DMD
Dentist
NPI: 1407547391Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
DN1859828(MA)
Research & Publications (20)
Glycoviruses: chemical glycosylation retargets adenoviral gene transfer.
PMID 15688429·Angew Chem Int Ed Engl·2005
8-other
Parasitism of Lygus spp. nymphs by the parasitoid wasp, Peristenus howardi, in the alfalfa seed-growing region of the Pacific Northwest.
PMID 17119626·J Insect Sci·2005
7-preclinical
Adenovirus retargeting and systemic delivery.
PMID 12894454·Ernst Schering Res Found Workshop·2003
6-review
Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.
PMID 19461878·PLoS Pathog·2009
7-preclinical
Quantitative characterization of cell transduction by HSV-1 amplicons using flow cytometry and real-time PCR.
PMID 19490970·J Virol Methods·2009
7-preclinical
Stopping a trial early in oncology: for patients or for industry?
PMID 19150952·Ann Oncol·2009
8-other
Electrochemical and electrogenerated chemiluminescent studies of a trinuclear complex, [((phen)2Ru(dpp))2RhCl2]5+, and its interactions with calf thymus DNA.
PMID 19358569·Anal Chem·2009
7-preclinical
Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.
PMID 19357539·J Thorac Oncol·2009
8-other
P-selectin dependent targeting to inflamed endothelium of recombinant P-selectin glycoprotein ligand-1 immunoglobulin chimera-coated poly[N-(2-hydroxypropyl) methacrylamide]-DNA polyplexes in vivo visualised by intravital microscopy.
PMID 19219895·J Gene Med·2009
7-preclinical
Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.
PMID 19272448·Cell Signal·2009
7-preclinical
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
PMID 19257852·Hum Gene Ther·2009
7-preclinical
Phase I study of cediranib in combination with oxaliplatin and infusional 5-Fluorouracil in patients with advanced colorectal cancer.
PMID 19228749·Clin Cancer Res·2009
3-trial
In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.
PMID 19248141·J Gene Med·2009
7-preclinical
Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
PMID 19363466·Cancer Gene Ther·2009
7-preclinical
Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.
PMID 19166885·J Control Release·2009
8-other
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
PMID 19424581·Int J Oncol·2009
3-trial
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial.
PMID 19667274·J Clin Oncol·2009
8-other
Preclinical screening of gene therapy in human tissues.
PMID 19348049·Hum Gene Ther·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 188 LONGWOOD AVE
BOSTON, MA 02115 - Phone
- (617) 432-1434
Quick Facts
- NPI
- 1407547391
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile